Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma

NCT05896228 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma
Relapsed Multiple Myeloma

Interventions

DRUG: Iberdomide
DRUG: Carfilzomib
DRUG: Daratumumab
DRUG: Dexamethasone
DRUG: Acetaminophen
DRUG: Diphenhydramine
DRUG: Montelukast

Sponsor

Benjamin T Diamond, MD

Collaborators

[object Object]